ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000786.1|O-antigen_1 # 2 # 1204 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.603	BGC0000786.1|O-antigen_1 	2	1204	+	Loose	650	26.1794	TriA	30.36	3003679	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TCGACCGGCTGGCGCGCGACCGATATCGTTGAGTATGTAAAAGTTCTGCTGATGAGTCGCGGCGGCGACCTCGGCATGATGATCATGATGCTGTGCGGTTTTGCCGCCTATATGACCCATATCGGTGCCAACGATATGGTGGTCAAGCTGGCCTCCCGCCCGCTGCGCTATATTAACTCGCCCTATATTTTAATGATTGCGGCCTACTTTGTCGCCTGCCTGATGTCGCTGGCCGTTTCGTCGGCCACCGGGCTGGGAGTATTGCTGATGGCAACCCTGTTCCCGGTGATGGTCAACGTGGGGATCAGCCGGGGGGCGGCGGCGGCGATCTGTGCCTCGCCTGCGGCGATCATCCTGGCTCCGACCTCCGGCGATGTGGTGCTGGCAGCCAAGGCGTCCGAAATGCCGCTGATCGACTTTGCCTTTAAAACAACCCTGCCCATCTCCATCATCGCTATCGTCTGTATGGCGATTGCCCACTACTTCTGGCAGCGCTACCTGGACAACAAGGAGCAGGCGCAGCACGAGATACTGGACGTCAACGAGATCACCACCACGGCACCCTCGTTTTATGCCATTCTGCCCTTTACGCCGATCATCGGCGTGCTGGTGTTCGACGGTAAGTGGGGGCCACATCTGCACATCATCAGCGTCCTGGTTATCTGTATGCTGCTGGCCTCGGTGACTGAGTTTTTGCGCAGCTTCGACGCTAAAAAGGTCTATAGCGGGCTGGAGGTGGCCTACCGCGGGATGGCGGACGCCTTTGCCAGCGTGGTGATGCTGTTGGTGGCCGCCGGGGTCTTTGCCCAGGGGCTGAGCACCGTCGGCTTTATCAGCAGCCTGATCGAGCTGGCCCAGTCCTTTGGCACCGGTGGCATCATCATGATGCTGGTGCTGGTGGTGATCACCATGCTGGCGGCGATGACCACCGGCTCCGGCAACGCGCCGTTCTACGCCTTTGTCGAGTTGATCCCCAAGCTGTCCGGCCAGATGGGCATCAACCCGGCCTACCTGACCATTCCGATGCTGCAGGCCTCCAATCTGGGCCGCACCCTATCGCCGGTTTCCGGTGTGGTGGTGGCTGTCTCCGGGATGGCCAAGATCTCCCCCTTTGAGGTGGTTAAACGCACCTCGGTGCCGGTGCTGGTCGGCCTGGTGGTGGTGATCGTCGCCACCGAGTTTATGGTACCGCTGCACCGCTGA	STGWRATDIVEYVKVLLMSRGGDLGMMIMMLCGFAAYMTHIGANDMVVKLASRPLRYINSPYILMIAAYFVACLMSLAVSSATGLGVLLMATLFPVMVNVGISRGAAAAICASPAAIILAPTSGDVVLAAKASEMPLIDFAFKTTLPISIIAIVCMAIAHYFWQRYLDNKEQAQHEILDVNEITTTAPSFYAILPFTPIIGVLVFDGKWGPHLHIISVLVICMLLASVTEFLRSFDAKKVYSGLEVAYRGMADAFASVVMLLVAAGVFAQGLSTVGFISSLIELAQSFGTGGIIMMLVLVVITMLAAMTTGSGNAPFYAFVELIPKLSGQMGINPAYLTIPMLQASNLGRTLSPVSGVVVAVSGMAKISPFEVVKRTSVPVLVGLVVVIVATEFMVPLHR	MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP	104.44	gnl|BL_ORD_ID|2002|hsp_num:0	2192			108	276	triclosan
BGC0000786.1|O-antigen_2 # 1331 # 1501 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.345	BGC0000786.1|O-antigen_2 	1331	1501	+	Loose	650	21.9422	tet(X1)	42.31	3005166	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGGCGGCAGATGCAGATGCAGATATTGGTTATATACACAGGGTGATATACAATAATCGGAAAGATAAATTGTATGATAATTGGCCGTCGGAGTTTGAAAATAAAAATTTGAGATGTTTTACCTTTTTTCTATTAAGTATAAAAATTAGTGCTGCTTGTGTCCACTGGTGA	MAADADADIGYIHRVIYNNRKDKLYDNWPSEFENKNLRCFTFFLLSIKISAACVHW	MANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAMKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKNDTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFIIQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGLDFKPTKSVSEFLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQQLMNV	15.60	gnl|BL_ORD_ID|4803|hsp_num:0	3888			708	783	tetracycline; minocycline; oxytetracycline
BGC0000786.1|O-antigen_3 # 2082 # 2342 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.452	BGC0000786.1|O-antigen_3 	2082	2342	-	Loose	275	23.8682	AAC(6')-Iai	53.33	3002575	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGATGTTATTCGCCTCGGCGTGCGTTTTTTTAAGTGCGAATAATGACGGTGTTAATGCCGATTTTGGATGTTCTTATTGTATCCCGGACATCGGATCCGTTGAATACCATTTCAGTAATTTGCTCTTTAACTCCGAGCTTACGGGCTTCATAGGTATAAGAGAGCAGGAATATAGGGTACCAATCACGACAGCGGACCCGGTCACAGCCCTTAAAGGTTGTAAACCTGAGCAGACTGAAAATGGGAGCAGTGAGCGTTAA	MMLFASACVFLSANNDGVNADFGCSYCIPDIGSVEYHFSNLLFNSELTGFIGIREQEYRVPITTADPVTALKGCKPEQTENGSSER	MKYTIIDIKDSETYITQAAEILFDVFSEISPESWPTLQKAKEDVIECIEGENICIGIIINKELIGWIGLREMYKKTWELHPMVIKKTHHNMGFGKILINEIEKKARERNLEGIVLGTDDETYRTSLSMIELNNENILQEIKNIRNLENHPYEFYKKCGYCIIGVIPNANGKNKPDILMWKNIMEENCG	45.74	gnl|BL_ORD_ID|1465|hsp_num:0	1602			168	213	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000786.1|O-antigen_4 # 2354 # 2746 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	BGC0000786.1|O-antigen_4 	2354	2746	+	Loose	200	25.0238	vanT gene in vanN cluster	26.88	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAAGATGTGGCGCTTATCTGCGAACTCGATGGGCAATAGCGTTTCGTCGGAATCAAAACCCGACAACACTGGTTTTGGTATGCATACAACACCACAACAGATGGCGTTCTGGTGTTATAGGTTTGGACCACGTACTTATGATATATTCCGTGAGCTGCTGATTCTGCTTACATCGTTTAATCTCGGCATGATAGCCAGCGATGACTGGGTCCGTTATGCCAGAGAATTCCCGAAAGAGATGCCTCTGATCGGTAAAATATTTACTCAGCGGATTGTGCATAATAATCTGATACTTTGCACCCGCATTCAGCGGCTGAATCGTAAAACAAGCTCAGCTAAGATTAACGGGAAAAGCATTGGTACCTTCATAGAAAAATATATGTTCTACTAA	MKMWRLSANSMGNSVSSESKPDNTGFGMHTTPQQMAFWCYRFGPRTYDIFRELLILLTSFNLGMIASDDWVRYAREFPKEMPLIGKIFTQRIVHNNLILCTRIQRLNRKTSSAKINGKSIGTFIEKYMFY	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	18.57	gnl|BL_ORD_ID|4745|hsp_num:0	1983			435	714	vancomycin
BGC0000786.1|O-antigen_5 # 2984 # 4231 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.323	BGC0000786.1|O-antigen_5 	2984	4231	+	Loose	700	26.1794	mdtG	22.95	3001329	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGTTCACTTCTAAAAAATTCCATATCTTTACTTGCAATGCAAGGGATTAACTACATACTACCACTAGTAACGCTACCTTACTTGACTAGAGTTCTGCATGTATATCCATTTGGTATATATAGTGCAACGATGAGTGTTGGCGCTTATGTAATATTGTTCATAAATTTTGGTTTTGATCTTAGTGCGACGAGGAAAATCGCAAAAAACAAGGGTGATAATTATGCTATTAGCGCCATATTTTTTAATGTTATCTTGGCTAAGTTTTTGTTATTTTTTCTCTCGCTTGTTATCGTGTTTTTATTGCTTTATACGATTGATTCATTTTATCCTATTAGGTCTTTATTCTTTTTATTAATACCTCAGTTTATTGGCTGTGTTTTTTTTCCTGCTTGGTTATATCAAGGGGTGGAGCGGTTATATCTAATATCAGCAATAACATCTGCCACAAAGCTATTAATTATTCCTCTGTTTTTTTTATTTGTAAGAGATGCTGGTGATATTGATAAAGCTATAATTATCTCTGGTTTCCCGCTGTTCTTTTCTGGTATCATTGGTTTTTATCTAGCATATAAGTTAAATATCATCAACTTTTCAGATGTGAGGGTAAGGGTTAATGATGCTATTCTTTTGATAAAAGAATCTACTTCTGTTTTTATTGGGGCTGTGGCTATAAGTATATATACGGCATGTACTCCAATTATTTTAAGCATTGTTAGTAATTATACTGAGGTCGGCTATTTTTCAGCAGTAGATAAATTAAGAAGTGCTATTTTAGGTATGTTTATTGTGCTAGGTCAGGTTTTTTATCCAAGAGCTACTGTTTTGTTTGAAAGTAATTTTTCAAAATATAAGCTATTTATAAGGCGAATTATTTTTTCGCAGATTATTTTTGGCGGGGTTGGGACGATATTATTTTATTTCTTCATGCCAATCATTGCGCCATTTATTTTAGGGCGTGGTTTTCATGGGTTGACAGAGCTCATTGAAATAATGGCCCCAATGATATTATTAATTCCTTTGTCTGTAATATTCTCTAATTGCATTCTACTGCCAATGGGGAAGAGTAAATTGTTTTATATTGCTCCCATAATAACAGCTATAATACATTTGCCATACTCTATTTATTTGAGTGAAAAGTATGGCGCTTTTGGTGGCGGGGTCTCGATATTAATAACTGAGGTCCTTAGTTTAATGTTGTTAGTGTTTTTTTCTTATAAATACGCAAATTTGAAAAGCATTTTTTGA	MSSLLKNSISLLAMQGINYILPLVTLPYLTRVLHVYPFGIYSATMSVGAYVILFINFGFDLSATRKIAKNKGDNYAISAIFFNVILAKFLLFFLSLVIVFLLLYTIDSFYPIRSLFFLLIPQFIGCVFFPAWLYQGVERLYLISAITSATKLLIIPLFFLFVRDAGDIDKAIIISGFPLFFSGIIGFYLAYKLNIINFSDVRVRVNDAILLIKESTSVFIGAVAISIYTACTPIILSIVSNYTEVGYFSAVDKLRSAILGMFIVLGQVFYPRATVLFESNFSKYKLFIRRIIFSQIIFGGVGTILFYFFMPIIAPFILGRGFHGLTELIEIMAPMILLIPLSVIFSNCILLPMGKSKLFYIAPIITAIIHLPYSIYLSEKYGAFGGGVSILITEVLSLMLLVFFSYKYANLKSIF	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	101.72	gnl|BL_ORD_ID|550|hsp_num:0	603			498	834	fosfomycin
BGC0000786.1|O-antigen_7 # 4791 # 5954 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.294	BGC0000786.1|O-antigen_7 	4791	5954	+	Loose	400	28.4906	IND-1	25.84	3002256	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGTTTCCTACAAAAGAGTTTAAGTATTTTGACTTTTTTTGTGTAATAGAGGGATTGTTCAAAGTGTTGCTCTCAAAATTGTCCGTTAATCGTAGTGTGAATCTTTTGTTTTTTTATTTGTTTTTTTCTGTCTTTGTGTTGATATTTATATTCAAGCCTCCGTTTCATTTTTTTTTGCTAAACGCATTATTTATTCATGTATATTCACTGGTTGCTTTGATTTTCTCTTTTTTCTATAGAGTAAAGCGAAAATATATCATCATCTTTTTTATTTTTTTATTCCCATTAAGTTATTTGACTATTATGGACAGAGTTACTGCTGCATATCCGCTTGTGGTGGCTCTTTTTTCATTATTAATCATCTCTGATAAGTTTCAGTTTCATAATTACTCCTGTCGCAATTTAACGCACTTTATTTTAATTTCTACTGTTCTTTTTTCATTTTTATTTCTGTATGAATCACACATCGATCGTTATTCGTTAGTTAATGGCGATCCTAACTATACCAGTTTGATCTTATTAACTGTGCTACTTATTTCTTTTGTATTTTCTGTGAGTAATAAGCTTAAAGTGTTAGTTTTATTATTAATGCTTTTTGTTGTTTATTTGACAAAATCAAGAACGGCAATATTGGCTTTGGCTGCATTTTTTCTATGTTGTAAGATTAAGCGGAAATTATTGTTGTTCTATTTTATATTATTTGTGTCTATAGCCTCTCAGTATTTCTTTTCATACATATTCCCTTCAATACTGTCTGATCTCGATTTCGGCCATAGCCGATTTTTTGATTTAAATGATGCCAGTAATATGGAAAGGATAACTATTTATAAGGAGGCCGTGGATTTTATATTATCCCATTTTACTCACTTTATTATTAATGGGGTGACTAATTATTTAGAAATAAACAAGTTGGCTACTAATATACCACATAATTGGTTTATCCAGTTTATTCTTGGGTTTGGGTTTTTATTTTCTATTTATTATTTGGCGGTGGTTGTTTTTGTTGCAAAAATAGTTTCTGGTAAGTCTTATTATCTATTGGCTTTTATGTGTTTTTTCTTTGTTTATGCATCATTTCTCAGTTATTATTCTTTAGCAACTCCATTATTATTTTTGGTGTTATCTCTATTCGTGTGCCATAGTATTGAAAGAGTGGCGAGATAA	MFPTKEFKYFDFFCVIEGLFKVLLSKLSVNRSVNLLFFYLFFSVFVLIFIFKPPFHFFLLNALFIHVYSLVALIFSFFYRVKRKYIIIFFIFLFPLSYLTIMDRVTAAYPLVVALFSLLIISDKFQFHNYSCRNLTHFILISTVLFSFLFLYESHIDRYSLVNGDPNYTSLILLTVLLISFVFSVSNKLKVLVLLLMLFVVYLTKSRTAILALAAFFLCCKIKRKLLLFYFILFVSIASQYFFSYIFPSILSDLDFGHSRFFDLNDASNMERITIYKEAVDFILSHFTHFIINGVTNYLEINKLATNIPHNWFIQFILGFGFLFSIYYLAVVVFVAKIVSGKSYYLLAFMCFFFVYASFLSYYSLATPLLFLVLSLFVCHSIERVAR	MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKKGVVLFDVPWEKIQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK	161.92	gnl|BL_ORD_ID|930|hsp_num:0	1009			48	303	
BGC0000786.1|O-antigen_8 # 6029 # 6814 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.318	BGC0000786.1|O-antigen_8 	6029	6814	+	Loose	500	72.4034	LpsA	30.67	3005052	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAAAACTTTTATTATATCCTTGAAAGATGAAGTCGCTCGTAGAAATAGCATTAGCGATAGGTTACATCATCATGACTTCGAGTTTTTTGATGCGGTTGATTTGAGAGTGGCATCAGATGATGTGCTTTCAGCGGTAAAATGTAAAAATATTAATTATAAACATCCAGCAATTAGAGAGCATATGACAAAAGGAGAGATTGGATGTGCTTTAAGTCATATGCAGCTATATAAAAAAATTGTTGATGATAATTTAGCATTTGCTAGAGTAATTGAAGATGATGCGGTTATTTTAAATCATGATGAAAAGATTCTTAATGATTTCATATTGGCTTTGGAAATGAAGAATATAGACTGGGATATCATGTTGCTGGGATATTCTAAGTTAAAAGCATGTGATTCTTTTGGTTTTTATCTTAAGGAGCCAATTAAAAATATCGTAAAGAGCGGTGCATACTCTTTAGGAATACCATTTAGGAACTGGACTTGTGGAACGGTAGGATATCTGGTTTCTCAAAGTGGTGCAAAGAAAATGATTAATAATGCTGCCTTTGGTAAGGTATGCACTGTTGCTGATGATTGGCTTTTTTTTGAAAAAAATTATAATTTAAAAATACTTCATATAAGACCTCTAATTGTATTGGAGGACTTTGAGTCGTATGAAAGTTCAATAGAGACAGATAGAAAAACTTATGTTAATCATGAATCACATATCTCATTCTTTTTAAGAGTTATGAGAGGGGTTGTAAGGAAAGTATATTTATCTATCTCTTGGAAAAGTTTATGA	MKTFIISLKDEVARRNSISDRLHHHDFEFFDAVDLRVASDDVLSAVKCKNINYKHPAIREHMTKGEIGCALSHMQLYKKIVDDNLAFARVIEDDAVILNHDEKILNDFILALEMKNIDWDIMLLGYSKLKACDSFGFYLKEPIKNIVKSGAYSLGIPFRNWTCGTVGYLVSQSGAKKMINNAAFGKVCTVADDWLFFEKNYNLKILHIRPLIVLEDFESYESSIETDRKTYVNHESHISFFLRVMRGVVRKVYLSISWKSL	MHNAAQHNYVISLTTEQKRRKHITEEFGKQNIPFEFFDAITPDIIEETAKKFNITLDRSPKAKLSDGEIGCALSHIVLWDLALENNLNYINIFEDDIHLGENAKELLEIDYISDDIHVLKLEANGKMFFKQPKSVKCDRNVYPMTVKQSGCAGYTVTAKGAKYLLELVKNKPLDVAVDSLVFEDFLHFKDYKIVQLSPGICVQDFVLHPDNPFESSLQEGRDRVHGNQRKFSILEKIKNEFGRVKIKMFGKQVPFK	101.95	gnl|BL_ORD_ID|2782|hsp_num:0	3794			21	663	polymyxin B; defensin
BGC0000786.1|O-antigen_9 # 6811 # 7911 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.343	BGC0000786.1|O-antigen_9 	6811	7911	+	Loose	700	79.337	LpsB	23.31	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAAAATACTATATGTTATTACAGGGTTAGGGTTGGGTGGGGCAGAGAAACAACTTTCTTTATTAGCAGATAATTTTACTGCTAGAGGTGAGCAAGTTTCAATCGTTTATTTAACCGGAGAGGTACTGGTTAAGCCGAAAAACAAAAATATAAAAATATATAATCTAGGTATAGATAAAAGTTTTTCTTCACTAATCAAGGGGATCTGGAAACTAAAATCAATAATATCTGACGTTAGGCCTGATGTGATCCATTCGCATATGTATCATGCTAATATCTTAGCTCGTATTTCATGTTGCCTTTCCCTATTTTCATCTAGGTTAGTGTGCTCGGCTCATAATAAAAACGAGGGGGGGCGAGTTAGGATGATTATTTATCGAATGACTGATTTTCTATGTGCTAAAACAACAAATGTTAGTCAGGAAGCTCTGGATGAGTTTATAACTAAGAAAGCATTTAGAAAAAGAAAGTCTAGTTTAGTCTATAATGGAATAGATCTTTCTATCTTTAAAAAGAAAAGCACTAATATTCAAAATATTAAAAATAAATTAGGAATAAATTTTGATGAGAAGGTGATATTTTGTGCAGGTAGATTAACAGAAGCAAAAGACTATCCTAATTTGATCCTCGCAATATCTAAGATGCACCAGAAAAAATGTAAGATTATCATTGCTGGTGATGGTCCCATGCGTAGTGATATAGAGAGACTAATTGATCGTTGCCATCTATCGCATCGGATTTTACTTATTGGGATAATTGATAATATTTCTGATTACTATAATTTATCTGATCTATTTGTATTGCCATCTCGCTGGGAGGGTTTTGGGTTAGTTGTCGCAGAGGCTATGGCATGTGAATGCCCAGTGATAGCAACTGATGCAGGGGGTGTTGCTGAGGTTCTTTCTAATGCTGATTGGCTGGTTCCAATTGCTGATAGCAGTAAATTAGCTGAGAAAATTGATGAGTTTTTTTTGCTTGACTCTTCAGAAGTTAAAGATATCAAAGCGAAAAACAAAGACCATTGTGAGAACCAATTTTCCATTGGGGCTATAATTAATAATTGGTATGCCATTTATAATGGGATAAGATCGAAATTATAA	MKILYVITGLGLGGAEKQLSLLADNFTARGEQVSIVYLTGEVLVKPKNKNIKIYNLGIDKSFSSLIKGIWKLKSIISDVRPDVIHSHMYHANILARISCCLSLFSSRLVCSAHNKNEGGRVRMIIYRMTDFLCAKTTNVSQEALDEFITKKAFRKRKSSLVYNGIDLSIFKKKSTNIQNIKNKLGINFDEKVIFCAGRLTEAKDYPNLILAISKMHQKKCKIIIAGDGPMRSDIERLIDRCHLSHRILLIGIIDNISDYYNLSDLFVLPSRWEGFGLVVAEAMACECPVIATDAGGVAEVLSNADWLVPIADSSKLAEKIDEFFLLDSSEVKDIKAKNKDHCENQFSIGAIINNWYAIYNGIRSKL	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	100.00	gnl|BL_ORD_ID|2781|hsp_num:0	3793			0	939	colistin A; colistin B; defensin
BGC0000786.1|O-antigen_10 # 7913 # 8950 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.318	BGC0000786.1|O-antigen_10 	7913	8950	+	Loose	700	37.3502	LpsB	19.31	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAAAAAAATATTTTTTGTAATTACAAAATCAGAGATTGGCGGTGCGCAAAAGTGGATTGTTGAGCTATCCAATATTTTAAAAGAACAATATGAAATTTTCATTATTACATCTGGAGATGGATGGCTAACATCAAAATTTGATTCATCTCACGTCATTCTTTACCCAGGGTTATTGAATCTTAAGAGTATTTTTTGTTTTTTTAAATTGGCTAATATATTTCGGAAATATAAAGCTGATATCGTTATTTCAAGCTCTGCAAATGCTGGGGTTTATGCGAGGTTATCTAAATTCCTATATTCTCATAAAAGCATTTATGTTTCCCATGGATGGTCTTGTCTTTATAATGGCGGAAGATTAAAAAAGATACAGTGCTTGGTTGAAAGATTTCTATCATTAATTTCAGATAAAATACTATGTGTTTCTGAGAATGATATGAATAATGCTATAAAATTTATAGGGATAAAAGAAAAAAAATTATTTGTCATTAGAAATGGTGTTAGCCCCCTGAAAAAAAAGAATGTTATTAATGTGAGAAAGAAAGTCCTCTTTGTTGGAAGAATGATTCATCCCAAAAGACCCGATTTGTTCGTCGCTGTAGCAGACAGTTTTCCTGATGTGGATTTTTATCTGGTAGGTGATGGTCCTCTAAAACAAAGGTTAGAGACATCCTGTCAACATAATAATGTTTATTTTCTTGGCGAGATTAATGGGTTTGACAGTTTTCAGTGCTATGATATTTTTGTACTTTGTTCTGATAGTGAAGGTTTACCTATGTCAGCATTGGAAGCCGCTTCTTCTGGGGTGCCTATTTTATTAAGTGATGTAGGTGGTTGTTCTGAACTAATTACTTTAATGAATAATGGATGTAGTAATGGCGAGTTATTTTCTAATGATATATCTTCGTTAAGATGTAAGTTAGGTGCTGTTTTGCTTGAATATGATAAATATTTTTCATCTGCTCAGGTTGTAAGCGGTTGCTTTGATATAAACAATCTTGCTGAAAAATATATTGAATTAATTGAGGGTGATAAATGA	MKKIFFVITKSEIGGAQKWIVELSNILKEQYEIFIITSGDGWLTSKFDSSHVILYPGLLNLKSIFCFFKLANIFRKYKADIVISSSANAGVYARLSKFLYSHKSIYVSHGWSCLYNGGRLKKIQCLVERFLSLISDKILCVSENDMNNAIKFIGIKEKKLFVIRNGVSPLKKKNVINVRKKVLFVGRMIHPKRPDLFVAVADSFPDVDFYLVGDGPLKQRLETSCQHNNVYFLGEINGFDSFQCYDIFVLCSDSEGLPMSALEAASSGVPILLSDVGGCSELITLMNNGCSNGELFSNDISSLRCKLGAVLLEYDKYFSSAQVVSGCFDINNLAEKYIELIEGDK	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	94.26	gnl|BL_ORD_ID|2781|hsp_num:0	3793			3	936	colistin A; colistin B; defensin
BGC0000786.1|O-antigen_13 # 10823 # 11839 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.580	BGC0000786.1|O-antigen_13 	10823	11839	+	Loose	1200	31.5722	arnA	23.56	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGCAATTTTAGTGACCGGCGGCGCCGGCTATATCGGTTCTCATACGGTGCTGGCGCTGCTGTCCCGTGGGGATGAGGTGGTAGTGCTGGATAACTTTGTCAACGCCTCTGTGCAGGCGCTGGCCCGGGTGGAGCAGATTTGTGACCGCCAACCCCACCTATACCGCGGTGATGTGCGCGATCGGGCGCTGCTGCAGCAGATTTTTGCACAGCACGTCATTAGCGATGTGATTCACTTCGCCGGTCTAAAGGCCGTGGGTGAGTCGGTGGAAAAACCGCTTGAGTACTACGACAACAATGTCAGCGGTACGCTGGTGTTGCTGGAAGAGATGCGCCGCGCCGGCGTGCAGGGCTTTATCTTTAGCTCCTCGGCGACGGTGTATGGCGATCCGGAGTCAGTGCCGTTGACGGAAAGCAGCCGTACCGGCGGGACGACCAACCCCTATGGCACCTCCAAGCTGATGGTCGAGCAGATCCTGCAGGATGTATCCCGCGCTAGACCTGAGATGCGGATTACCGCGCTGCGCTACTTTAATCCGGTGGGAGCTCATCCATCGGGGCTTATCGGTGAAGATCCCAACGGGATACCCAATAATCTGATCCCTTATGTTGCTCAGGTGGCGGTGGGAAAACTGGCCTGCCTGTCCATCTTTGGCCATGATTATCCCACACAGGACGGCACCGGGGTACGCGACTATATTCACGTGATGGATCTGGCCACCGGCCACCTTGCCGCACTCGATCGTCGCGATGAGGGGGCCAGCTATAAAGTGTATAACCTGGGGACGGGCGTCGGGTATTCTGTTTTGGATATCGTTGCCGCATTTGAGAGGTGCTCCGGGGTTACTATACCTTATCGCTTTGCACCGCGCCGCGCGGGTGATATCGCCGAGTGTTGGTCCAATCCCGCCTTGGCGGCGCAAGAGTTGGGTTGGTGTGCGCAGTATGGTCTGGAGGCGATGATGACCGATACCTGGCGCTGGCAGCAGAACAACCCGAATGGATACCAGGATTAA	MAILVTGGAGYIGSHTVLALLSRGDEVVVLDNFVNASVQALARVEQICDRQPHLYRGDVRDRALLQQIFAQHVISDVIHFAGLKAVGESVEKPLEYYDNNVSGTLVLLEEMRRAGVQGFIFSSSATVYGDPESVPLTESSRTGGTTNPYGTSKLMVEQILQDVSRARPEMRITALRYFNPVGAHPSGLIGEDPNGIPNNLIPYVAQVAVGKLACLSIFGHDYPTQDGTGVRDYIHVMDLATGHLAALDRRDEGASYKVYNLGTGVGYSVLDIVAAFERCSGVTIPYRFAPRRAGDIAECWSNPALAAQELGWCAQYGLEAMMTDTWRWQQNNPNGYQD	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	51.06	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1488	polymyxin B
BGC0000786.1|O-antigen_14 # 11863 # 12213 # 1 # ID=1_14;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.556	BGC0000786.1|O-antigen_14 	11863	12213	+	Loose	700	181.8	ugd	73.5	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAGATAGCGATTAGCGGTACGGGCTACGTCGGCCTGTCCAATGGAATTTTGCTGGCTCAGCATCATGAGGTGGTGGCGCTGGATATTGTGGCGGAAAAGGTCGGGATGCTTAACCGGCGTCAGTCACCGATCGTGGATAAGGAGATCCAGGAGTACCTCACTAACCGCTCCCTGAATTTCCGCGCGACGCTGGACAAGGAAGAGGCGTACCGCGGCGCTGATTTTGTCATTATCGCGACGCCGACCGACTATGATCCCAAGAGTAATTACTTTAACACCGCCAGCGTAGAGGCGGTGATCCGCGATGTGCTGGCGATTAACCCGGCGGCGGTGATGATCATCAAGTCG	MKIAISGTGYVGLSNGILLAQHHEVVALDIVAEKVGMLNRRQSPIVDKEIQEYLTNRSLNFRATLDKEEAYRGADFVIIATPTDYDPKSNYFNTASVEAVIRDVLAINPAAVMIIKS	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	30.15	gnl|BL_ORD_ID|894|hsp_num:0	842			0	351	polymyxin B
